• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Announces $10 Billion Variable Annuity Risk Transfer Transaction

    4/30/25 4:13:00 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    • Agreement with a subsidiary of Talcott Financial Group to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves
    • Transaction demonstrates MetLife's focused execution across New Frontier strategic priorities

    MetLife, Inc. (NYSE:MET) today announced it has entered into an agreement with Talcott Resolution Life Insurance Company (Talcott), a life insurance and annuities subsidiary of Talcott Financial Group, to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves.

    The combined value of the transaction is expected to be approximately $250 million consisting of both ceding commission and capital released over time.

    The planned reinsurance transaction with Talcott is aligned with MetLife's disciplined evaluation of risk transfer options within MetLife Holdings, the closed-block businesses of the company's former U.S. Retail segment. The transaction will accelerate the run-off of MetLife's legacy business and is the latest example of executing across the company's New Frontier strategic priorities.

    MetLife anticipates that the transaction will positively reduce the company's enterprise risk associated with capital markets. Importantly, the transaction will significantly lower the company's retail variable annuity tail risk by reducing account values by approximately 40%.

    Expected foregone annual adjusted earnings total of approximately $100 million will be offset by annual hedge cost savings of approximately $45 million.

    "This transaction represents another tool in our toolkit that is available to generate long-term value," said MetLife President and CEO Michel Khalaf. "It will reduce enterprise risk and bolster MetLife's position as a fundamental, all-weather performer. Our capacity to lower risk and successfully navigate uncertain and changing environments benefits our shareholders and all our other stakeholders."

    Summary

    • MetLife plans to reinsure approximately $10 billion U.S. variable annuity and rider reserves with Talcott.
    • As part of MetLife's ongoing commitment to its policyholders, the company will continue to be responsible for all customer-related functions.
    • The reinsurance transaction is structured on both a modified coinsurance and a funds withheld basis.
    • The transaction is expected to close in the second half of 2025. The consummation of the closing under the agreement is subject to the satisfaction or waiver of customary closing conditions specified in the agreement, including the receipt of required regulatory approvals.
    • MetLife Investment Management secured mandates to manage approximately $6 billion of assets under investment management agreements with Talcott.

    Investor Conference Call

    On Thursday, May 1, 2025, from 9-10:00 a.m. (ET), MetLife President and CEO Michel Khalaf and MetLife CFO and head of MetLife Investment Management John McCallion will host a call to discuss the company's first quarter 2025 earnings and address questions on the agreement with Talcott.

    The conference call will be available live via the internet. To listen to the conference call, click the following link to register (https://events.q4inc.com/attendee/259680312).

    The conference call will be available for replay via telephone and the internet beginning at 11:00 a.m. (ET) on Thursday, May 1, 2025, until Thursday, May 8, 2025, at 11:59 p.m. (ET). To listen to a replay of the conference call via telephone, dial 800-770-2030 (U.S.) or 647-362-9199 (outside the U.S.). The Conference ID for the replay is 34666 followed by # key. To access the replay of the conference call via the internet, visit the MetLife Investor Relations webpage (https://investor.metlife.com).

    Advisors

    Organizations representing MetLife on this transaction include Goldman Sachs & Co. LLC (financial advisor) and Willkie Farr & Gallagher LLP (legal counsel).

    Forward-Looking Statements

    This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They use words and terms such as "anticipate," "are confident," "assume," "believe," "continue," "could," "estimate," "expect," "if," "intend," "likely," "may," "plan," "potential," "project," "should," "target," "will," "would," and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. They include statements relating to strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. By their nature, forward-looking statements: speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

    Many factors determine the results of MetLife, Inc., its subsidiaries and affiliates, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. MetLife, Inc. does not guarantee any future performance. Our results could differ materially from those MetLife, Inc. expresses or implies in forward-looking statements. The risks, uncertainties and other factors identified in MetLife, Inc.'s filings with the U.S. Securities and Exchange Commission, and others, may cause such differences. These factors include:

    (1) economic condition difficulties, including risks relating to interest rates, the effects of announced or future tariff increases on the global economy, credit spreads, declining equity or debt markets, real estate, obligors and counterparties, government default, currency exchange rates, derivatives, climate change, public health and terrorism and security;

    (2) global capital and credit market adversity;

    (3) credit facility inaccessibility;

    (4) financial strength or credit ratings downgrades;

    (5) unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers' credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks;

    (6) statutory life insurance reserve financing costs or limited market capacity;

    (7) legal, regulatory, and supervisory and enforcement policy changes;

    (8) changes in tax rates, tax laws or interpretations;

    (9) litigation and regulatory investigations;

    (10) unsuccessful efforts to meet all environmental, social, and governance standards or to enhance our sustainability;

    (11) MetLife, Inc.'s inability to pay dividends and repurchase common stock;

    (12) MetLife, Inc.'s subsidiaries' inability to pay dividends to MetLife, Inc.;

    (13) investment defaults, downgrades, or volatility;

    (14) investment sales or lending difficulties;

    (15) collateral or derivative-related payments;

    (16) investment valuations, allowances, or impairments changes;

    (17) claims or other results that differ from our estimates, assumptions, or models;

    (18) global political, legal, or operational risks;

    (19) business competition;

    (20) technological changes;

    (21) catastrophes;

    (22) climate changes or responses to it;

    (23) deficiencies in our closed block;

    (24) goodwill or other asset impairment, or deferred income tax asset allowance;

    (25) impairment of VOBA, value of distribution agreements acquired or value of customer relationships acquired;

    (26) product guarantee volatility, costs, and counterparty risks;

    (27) risk management failures;

    (28) insufficient protection from operational risks;

    (29) failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures;

    (30) accounting standards changes;

    (31) excessive risk-taking;

    (32) marketing and distribution difficulties;

    (33) pension and other postretirement benefit assumption changes;

    (34) inability to protect our intellectual property or avoid infringement claims;

    (35) acquisition, integration, growth, disposition, or reorganization difficulties;

    (36) Brighthouse Financial, Inc. separation risks;

    (37) MetLife, Inc.'s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and

    (38) legal- and corporate governance-related effects on business combinations.

    MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the U.S. Securities and Exchange Commission.

    Use of Non-GAAP Financial Measures

    "Adjusted earnings" refers to a measure that is not presented in accordance with accounting principles generally accepted in the United States (GAAP). "Adjusted earnings" should be read as "adjusted earnings available to common shareholders," and should not be viewed as a substitute for the most directly comparable financial measure calculated in accordance with GAAP, "net income (loss) available to common shareholders". More information about this measure may be found in our quarterly financial supplement and other documents, which are available on the Investor Relations portion of MetLife's website, www.metlife.com.

    About MetLife

    MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250430203791/en/

    For Media: Dave Franecki (973) 264-7465

    For Investors: John Hall (212) 578-7888

    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    SEC Filings

    See more
    • SEC Form S-3ASR filed by MetLife Inc.

      S-3ASR - METLIFE INC (0001099219) (Filer)

      5/16/25 5:01:44 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - METLIFE INC (0001099219) (Filer)

      5/15/25 4:20:25 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form 13F-HR filed by MetLife Inc.

      13F-HR - METLIFE INC (0001099219) (Filer)

      5/14/25 4:27:39 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Financials

    Live finance-specific insights

    See more
    • MetLife Declares Second Quarter 2025 Preferred Stock Dividends

      MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul

      5/15/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife Announces 1Q 2025 Results

      MetLife, Inc. (NYSE:MET) today announced its first quarter 2025 results. Earnings Per Share   Return on Equity (ROE) 1Q 2025   1Q 2025 Net Income $ 1.28   ROE 14.9 % Adjusted Earnings $ 1.96   Adjusted ROE 14.4 % Net income increased 10% to $879 million. Premiums, fees and other revenues (PFOs) increased 14% to $13.6 billion. Adjusted earnings rose 1% to $1.3 billion. Higher life underwriting margins, volume growth and variable investment income were partially offset by unfavorable foreign currency impacts and lower recurring interest margins. Book value increased 2% to $35.16 per share. A

      4/30/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife CFO John McCallion Provides First Quarter 2025 Financial Update Video

      MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a first quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430216095/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers b

      4/30/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on MetLife with a new price target

      BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

      1/23/25 7:50:09 AM ET
      $MET
      Life Insurance
      Finance
    • TD Cowen initiated coverage on MetLife with a new price target

      TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

      10/9/24 7:52:22 AM ET
      $MET
      Life Insurance
      Finance
    • Barclays initiated coverage on MetLife with a new price target

      Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

      9/5/24 8:14:53 AM ET
      $MET
      Life Insurance
      Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Assigns Indicative Issue Credit Ratings to MetLife, Inc.'s New Shelf Registration

      AM Best has assigned indicative Long-Term Issue Credit Ratings of "a-" (Excellent) to senior unsecured issues, "bbb+" (Good) to subordinated issues, and "bbb" (Good) to preferred stock to the recently filed shelf registration of MetLife, Inc. (MetLife) (headquartered in New, NY) (NYSE:MET). The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registrations, which expired. MetLife's proforma financial leverage and the historical interest coverage ratios are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on A

      5/21/25 10:10:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Names Jane Slusark as Chief Communications Officer

      MetLife, Inc. (NYSE:MET) today announced that Jane Slusark will join the company as chief communications officer, effective June 9, 2025. In this role, she will oversee the company's global communications strategy, including internal and external communications and media relations. "Jane brings strategic vision, operational rigor and deep expertise to this role," said Michael Roberts, chief marketing officer at MetLife. "She has a proven track record of building trust and deepening engagement, which will be instrumental as we continue to enhance our reputation with customers, employees, and communities around the world." Slusark comes to MetLife from Principal Financial Group, where she w

      5/19/25 1:01:00 PM ET
      $MET
      Life Insurance
      Finance
    • MetLife Declares Second Quarter 2025 Preferred Stock Dividends

      MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul

      5/15/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    See more
    • MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

      Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

      1/8/25 8:30:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Investment Management Names Kerry O'Brien Global Head of Insurance Asset Management and Liability Solutions

      MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh

      12/2/24 8:30:00 AM ET
      $MET
      Life Insurance
      Finance
    • MetLife Worldwide Benefits and GeoBlue® to Offer Joint Solution

      Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

      6/25/24 9:00:00 AM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Global Tech. & Ops. Pappas Bill sold $2,092,683 worth of shares (26,000 units at $80.49) and gifted 4,684 shares, decreasing direct ownership by 28% to 66,744 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      5/13/25 4:18:19 PM ET
      $MET
      Life Insurance
      Finance
    • Director Mumenthaler Christian Stephane was granted 353 units of Common Stock (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      5/5/25 4:03:34 PM ET
      $MET
      Life Insurance
      Finance
    • New insider Mumenthaler Christian Stephane claimed no ownership of stock in the company (SEC Form 3)

      3 - METLIFE INC (0001099219) (Issuer)

      5/2/25 11:22:03 AM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      12/18/23 5:20:05 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by MetLife Inc.

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      11/1/24 5:05:26 PM ET
      $MET
      Life Insurance
      Finance
    • Amendment: SEC Form SC 13D/A filed by MetLife Inc.

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      8/1/24 4:38:49 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

      SC 13D/A - METLIFE INC (0001099219) (Subject)

      5/2/24 5:34:57 PM ET
      $MET
      Life Insurance
      Finance